An advisory panel to the FDA has recommended Johnson & Johnson's experimental nasal spray, which has a compound similar to often-abused ketamine, for patients suffering from depression.
A cancer diagnosis more than quadruples the risk of suicide, suggests a study published online in Nature Communications.
Pharmacogenomics testing might help to identify less effective medications for patients with major depressive disorder, according to results from the GUIDED trial.
The US Food and Drug Administration (FDA) recently published a final order that requires manufacturers to file a premarket approval application for most uses of electroconvulsive therapy (ECT) devices.
Having post-traumatic stress disorder (PTSD), depression treated with antidepressants, or mental illness in general is linked with an increased risk of rapid eye movement (REM) sleep behavior disorder, according to a study published online in Neurology.
A new cohort study confirmed a previously reported association between treatment with antidepressants and hip fracture in older adults, but it contained a twist.
BLOG: These studies were the latest findings showing that psychedelics, erroneously dismissed as mere intoxicants and swept up in the hysteria of the Nixon-era drug wars, could prove to be as important to psychiatry as penicillin was to infectious disease.
I’m in London interviewing loved ones of doctors who have ended their lives by suicide.
We need to get the message out that for every death by suicide there is a cohort of bereaved family members who themselves become ill and suicidal. They require — and deserve — our best diagnostic and treatment efforts.
Psych Congress cochair Charles Raison, MD, recently discussed his research and perspectives in an extensive interview with Rhonda Perciavalle Patrick, PhD, who runs the FoundMyFitness website.
Saundra Jain, MA, PsyD, LPC, a Psych Congress Steering Commitee member, explains the Patient Health Questionnaire (PHQ-9), the gold standard measurement tool in major depression.
Mary Kay Lobo, PhD, an assistant professor at the University of Maryland School of Medicine, Baltimore, explains research which suggests a specific gene, Slc6a15, may be central to depression.